Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, and circulating variants have rendered monoclonal antibody treatments ineffective. In the new study in Clinical Infectious Diseases, researchers analyzed clinical data and concluded that among outpatients with COVID-19, antibodies to SARS-CoV-2 given...